Yes it is possible, but it must break above 14 and close above it on a daily basis.
QQQ broke the 20 day MA on Friday. Would love to see that level reclaimed for more upside in the market. Here are some levels I see for this week (note, these are intraday levels - not swing levels). Of course, this is just my opinion and I am not liable for your trading decisions. INO calls over 13.1 or 13.7 CRWD calls over 218.25 BYND puts under 177...
If this triangle breaks to the upside we could see big movements bullish for INO. This is not a time to enter, but when we a break through the red resistance where the yellow circle is, we could see that trend reversal in the next two weeks. If resistance is confirmed, expect a retest of about 9 dollars where we could possibly break below. NEUTRAL as of 1/26
INO seems to be a dog in the vaccine industry but maybe it can make some moves soon. The volume seems kinda light its just consolidating sideways. I bought at 10.15 and will play it something like this. At $11 I'll double down and as it approaches $13 I will sell half, if it gets to $15 and passes through it with high volume I'll add but watch out for a false...
Follow me for more clean charts
Currently shorts are controlling the stock. Seems that it found it's support and we might see a short squeeze in the upcoming 1-3 weeks.
We need to see volulme to commit to that great break. The upside of the trade is huge and a tight stoploss at every support would serve you well. Minimun 100 for daytrading and 50 for swing trade. Good luck!
Entered a swing calls Friday morning. First take profit point is the upcoming dotted red line (13.00) and the second take profit line is 18.55. I believe the momentum of a 2nd surge and upcoming catalysts with the massive 14 million dark pool buy right before the close on Friday will make INO rise in the short to mid term.
Ridiculous support + retest. Solid bullish call with the other vaccine-makers going bullish
Thanks @smallcapper on Stocktwits for reaching out! Here ya go!
see charts at www.tradingview.com $DGX Entry 120 Target 1 $125 Target 2 $130 Why DGX? FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use With Covid wave 2 on the rise, this could be a huge player. www.prnewswire.com What is DGX? Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest...
see full chart at www.tradingview.com Gild Entry $62 area Target 1 $67 Target 2 $71 stoploss $59 Why this play? Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside. What is Gild? Gilead Sciences,...
Currently 28.8% short interest with the Weekly just above the 200 EMA. Oversold Stoch and at the bottom of the MACD histogram. I'd expect anlarge short squeeze soon.
see full chart at www.tradingview.com GSK Entry $39.70 Target 1 $42.45 Target 2 $45.50 Target 3 $48 stoploss 38.70 Why this play? There are 4 general approaches to the Covid vaccine. 1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax) 2.Coronavirus proteins themselves, produced industrially in outside cell...